‹ KNSA latest research

KNSA (Kiniksa Pharmaceuticals Interna): every AI call and what happened next

TradeFlare's AI research teams analysed KNSA on 12 market nights between April 29, 2026 and September 25, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

12 calls 11 BUY · 1 HOLD · 0 SELL BUY calls up after 20 trading days: 8 of 10
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 25, 2026 BUY $75.34 $80.61 / $64.04 +0.9% not yet
The setup suggests a short-to-medium term bounce opportunity driven by fundamental strength and sentiment, with technicals showing oversold conditions.
August 28, 2026 HOLD $79.80 — / — -0.2% -2.5%
The stock is at a critical resistance level with conflicting technical signals, requiring further price action confirmation.
August 7, 2026 BUY $76.51 $92.00 / $64.98 +0.9% +2.4%
The current market regime and the stock's technical setup suggest a short-to-medium term trading opportunity.
June 30, 2026 BUY $62.41 $74.89 / $56.17 +1.3% +26.5%
The stock is showing strong momentum and is poised for further upside based on fundamental strength and positive sentiment.
May 29, 2026 BUY $50.84 $57.91 / $40.36 +0.1% +29.0%
The technical setup suggests a short-term oversold bounce, while fundamental and sentiment factors support a longer-term upward trend.
May 28, 2026 BUY $51.84 $57.91 / $44.06 -3.2% +16.4%
The fundamental and sentiment tailwinds suggest a sustained upward move, but technical consolidation requires patience.
May 27, 2026 BUY $52.86 — / — -7.7% +9.7%
The current market regime and the stock's neutral technicals do not support a conviction buy.
May 26, 2026 BUY $53.24 $57.65 / $43.78 -11.2% +11.9%
The current technical setup suggests a short-term oversold bounce opportunity within a longer-term uptrend, with fundamental and sentiment tailwinds supporting potential upside.
May 25, 2026 BUY $53.24 $63.30 / $44.84 -11.2% +11.9%
The technical setup suggests a potential bounce from oversold conditions, and the fundamental and sentiment are bullish, but the risk profile warrants a longer-term view to allow the trade to develop.
May 22, 2026 BUY $53.65 $59.02 / $48.29 -9.0% +11.7%
The stock is currently consolidating near resistance, and a clear catalyst is needed to initiate a buy in this neutral market.
April 30, 2026 BUY $52.99 — / — +5.9% -10.0%
Continued strong performance and market penetration of ARCALYST.
April 29, 2026 BUY $53.85 $60.00 / $45.77 +9.9% -4.1%
The neutral market regime and the high risk score necessitate a cautious approach, waiting for a clearer entry signal.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.